Bahl & Gaynor Dividend ETF holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.
Bahl & Gaynor Dividend ETF BGDV
Morningstar’s Analysis BGDV
Will BGDV outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 34.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Taiwan Semiconductor Manufacturing Co Ltd ADR | 4.89 | 42M | Technology |
Eli Lilly and Co | 3.96 | 34M | Healthcare |
Victory Capital Holdings Inc Class A | 3.79 | 33M | Financial Services |
AbbVie Inc | 3.48 | 30M | Healthcare |
Motorola Solutions Inc | 3.38 | 29M | Technology |
NVIDIA Corp | 3.27 | 28M | Technology |
Broadcom Inc | 3.19 | 28M | Technology |
UnitedHealth Group Inc | 3.04 | 26M | Healthcare |
Encompass Health Corp | 2.99 | 26M | Healthcare |
Targa Resources Corp | 2.80 | 24M | Energy |